Moderna sues Pfizer and BioNTech for mRNA patent infringement
CAMBRIDGE, MA, August 27, 2022—Moderna, Inc., a $53.5 billion biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, filed patent
Read more
spikevax
The FDA approves Moderna’s “Spikevax” vaccine
Yesterday, the Food and Drug Administration approved Moderna’s COVID-19 vaccine for individuals 18 years of age and older. Upon approval,
Read more